Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INtravitreal and Aqueous Dexamethasone Levels After DEXtenza

NCT04529512 is registered in ClinicalTrials.gov with Nathan Steinle as lead sponsor.

NCT NCT04529512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INtravitreal and Aqueous Dexamethasone Levels After DEXtenza
Lead sponsor
Nathan Steinle
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2021
Completion date
March 31, 2021
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ocular disease requiring surgery